Literature DB >> 20032197

Thyroid hormone antagonizes tumor necrosis factor-alpha signaling in pituitary cells through the induction of dual specificity phosphatase 1.

Marina Lasa1, Beatriz Gil-Araujo, Marta Palafox, Ana Aranda.   

Abstract

Pituitary function has been shown to be regulated by an increasing number of factors, including cytokines and hormones, such as TNFalpha and T(3). Both the proinflammatory cytokine TNFalpha and T(3) have been suggested to be involved in the maintenance of tissue homeostasis in the anterior pituitary gland. In this report we show that T(3) negatively interferes with MAPK p38 and nuclear factor-kappaB (NF-kappaB) activation by TNFalpha in GH4C1 cells. Our data demonstrate that MAPK p38 is specifically activated upon exposure to TNFalpha and that T(3) abolishes this activation in a time-dependent manner by a mechanism that involves the induction of the MAPK phosphatase, DUSP1. Our data show that the pool of up-regulated DUSP1 by T(3) is mainly localized to the cytosol, and that TNFalpha does not affect this localization. On the other hand, we show that T(3) impairs the activation of the NF-kappaB pathway induced by TNFalpha, producing a significant decrease in NF-kappaB-dependent transcription, phosphorylation of IkappaBalpha, translocation of p65/NF-kappaB to the nucleus, and p65/NF-kappaB transactivation potential. Interestingly, the overexpression of DUSP1 inhibits the NF-kappaB activation achieved by either TNFalpha or ectopic expression of the upstream inducer of MAPK p38. Conversely, DUSP1 depletion abrogates the inhibitory effect of T(3) on the induction of NF-kappaB-dependent transcription by TNFalpha. Overall, our results indicate that T(3) antagonizes TNFalpha signaling in rat pituitary tumor cells through the induction of DUSP1.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20032197      PMCID: PMC5428125          DOI: 10.1210/me.2009-0298

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  59 in total

1.  IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK.

Authors:  J D Woronicz; X Gao; Z Cao; M Rothe; D V Goeddel
Journal:  Science       Date:  1997-10-31       Impact factor: 47.728

2.  IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation.

Authors:  F Mercurio; H Zhu; B W Murray; A Shevchenko; B L Bennett; J Li; D B Young; M Barbosa; M Mann; A Manning; A Rao
Journal:  Science       Date:  1997-10-31       Impact factor: 47.728

3.  Mutual transcriptional interference between RelA and androgen receptor.

Authors:  J J Palvimo; P Reinikainen; T Ikonen; P J Kallio; A Moilanen; O A Jänne
Journal:  J Biol Chem       Date:  1996-09-27       Impact factor: 5.157

4.  The regulatory mechanism by which interleukin-6 stimulates GH-gene expression in rat GH3 cells.

Authors:  Feng-Ying Gong; Yi-Fan Shi; Jie-Ying Deng
Journal:  J Endocrinol       Date:  2006-08       Impact factor: 4.286

5.  Transcriptional activation of the NF-kappaB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1).

Authors:  Linda Vermeulen; Gert De Wilde; Petra Van Damme; Wim Vanden Berghe; Guy Haegeman
Journal:  EMBO J       Date:  2003-03-17       Impact factor: 11.598

6.  Negative interaction between the RelA(p65) subunit of NF-kappaB and the progesterone receptor.

Authors:  E Kalkhoven; S Wissink; P T van der Saag; B van der Burg
Journal:  J Biol Chem       Date:  1996-03-15       Impact factor: 5.157

Review 7.  A paradigm for gene regulation: inflammation, NF-kappaB and PPAR.

Authors:  Wim Vanden Berghe; Linda Vermeulen; Philippe Delerive; Karolien De Bosscher; Bart Staels; Guy Haegeman
Journal:  Adv Exp Med Biol       Date:  2003       Impact factor: 2.622

8.  Tumor necrosis factor-alpha in macrophages of heart, liver, kidney, and in the pituitary gland.

Authors:  M Arras; A Höche; R Bohle; P Eckert; W Riedel; J Schaper
Journal:  Cell Tissue Res       Date:  1996-07       Impact factor: 5.249

9.  Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1.

Authors:  Sonya M Abraham; Toby Lawrence; Anna Kleiman; Paul Warden; Mino Medghalchi; Jan Tuckermann; Jeremy Saklatvala; Andrew R Clark
Journal:  J Exp Med       Date:  2006-07-31       Impact factor: 14.307

10.  Glucocorticoids synergize with IL-1beta to induce TLR2 expression via MAP Kinase Phosphatase-1-dependent dual Inhibition of MAPK JNK and p38 in epithelial cells.

Authors:  Akihiro Sakai; Jiahuai Han; Andrew C B Cato; Shizuo Akira; Jian-Dong Li
Journal:  BMC Mol Biol       Date:  2004-05-04       Impact factor: 2.946

View more
  12 in total

1.  Thyroid Hormone Receptor β Inhibits Self-Renewal Capacity of Breast Cancer Stem Cells.

Authors:  Irene López-Mateo; Elvira Alonso-Merino; Cristian Suarez-Cabrera; Jeong Won Park; Sheue-Yann Cheng; Susana Alemany; Jesús M Paramio; Ana Aranda
Journal:  Thyroid       Date:  2019-12-30       Impact factor: 6.568

2.  The thyroid hormone receptors as modulators of skin proliferation and inflammation.

Authors:  Constanza Contreras-Jurado; Laura García-Serrano; Mariana Gómez-Ferrería; Clotilde Costa; Jesús M Paramio; Ana Aranda
Journal:  J Biol Chem       Date:  2011-05-12       Impact factor: 5.157

3.  Deciphering the regulatory logic of an ancient, ultraconserved nuclear receptor enhancer module.

Authors:  Pia D Bagamasbad; Ronald M Bonett; Laurent Sachs; Nicolas Buisine; Samhitha Raj; Joseph R Knoedler; Yasuhiro Kyono; Yijun Ruan; Xiaoan Ruan; Robert J Denver
Journal:  Mol Endocrinol       Date:  2015-04-13

4.  Dual specificity phosphatase 1 expression inversely correlates with NF-κB activity and expression in prostate cancer and promotes apoptosis through a p38 MAPK dependent mechanism.

Authors:  Beatriz Gil-Araujo; María-Val Toledo Lobo; María Gutiérrez-Salmerón; Julia Gutiérrez-Pitalúa; Santiago Ropero; Javier C Angulo; Antonio Chiloeches; Marina Lasa
Journal:  Mol Oncol       Date:  2013-09-14       Impact factor: 6.603

5.  The Thyroid Hormone Receptors Inhibit Hepatic Interleukin-6 Signaling During Endotoxemia.

Authors:  Constanza Contreras-Jurado; Elvira Alonso-Merino; Cristina Saiz-Ladera; Arturo José Valiño; Javier Regadera; Susana Alemany; Ana Aranda
Journal:  Sci Rep       Date:  2016-08-03       Impact factor: 4.379

6.  The ligand-bound thyroid hormone receptor in macrophages ameliorates kidney injury via inhibition of nuclear factor-κB activities.

Authors:  Fumihiko Furuya; Toshihisa Ishii; Shogo Tamura; Kazuya Takahashi; Hidetoshi Kobayashi; Masashi Ichijo; Soichi Takizawa; Masahiro Kaneshige; Katsue Suzuki-Inoue; Kenichiro Kitamura
Journal:  Sci Rep       Date:  2017-03-08       Impact factor: 4.379

Review 7.  Thyroid hormones act as modulators of inflammation through their nuclear receptors.

Authors:  Marina Lasa; Constanza Contreras-Jurado
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-08       Impact factor: 6.055

8.  Involvement of the cellular phosphatase DUSP1 in vaccinia virus infection.

Authors:  Ana Cáceres; Beatriz Perdiguero; Carmen E Gómez; Maria Victoria Cepeda; Carme Caelles; Carlos Oscar Sorzano; Mariano Esteban
Journal:  PLoS Pathog       Date:  2013-11-14       Impact factor: 6.823

Review 9.  Thyroid hormone signaling and adult neurogenesis in mammals.

Authors:  Sylvie Remaud; Jean-David Gothié; Ghislaine Morvan-Dubois; Barbara A Demeneix
Journal:  Front Endocrinol (Lausanne)       Date:  2014-04-28       Impact factor: 5.555

10.  Downregulation of Snail by DUSP1 Impairs Cell Migration and Invasion through the Inactivation of JNK and ERK and Is Useful as a Predictive Factor in the Prognosis of Prostate Cancer.

Authors:  Desirée Martínez-Martínez; María-Val Toledo Lobo; Pablo Baquero; Santiago Ropero; Javier C Angulo; Antonio Chiloeches; Marina Lasa
Journal:  Cancers (Basel)       Date:  2021-03-08       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.